SCHEMBL19003736

SCHEMBL19003736

CC/N=C\c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CA2 P00918 4/20 0.47
KMT2A Q03164 6/20 0.42
ALDH1A1 P00352 2/20 0.42
G6PC1 P35575 1/20 0.42
NOX1 Q9Y5S8 1/20 0.41
TAAR1 Q96RJ0 3/20 0.41
MEN1 O00255 5/20 0.41
CA1 P00915 2/20 0.41
GRIN2D O15399 2/20 0.40
GRIN3B O60391 2/20 0.40
GRIN1 Q05586 2/20 0.40
GRIN2A Q12879 2/20 0.40
GRIN2B Q13224 2/20 0.40
GRIN2C Q14957 2/20 0.40
GRIN3A Q8TCU5 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3443847 1.00 LMNA (0.52) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL1101650 1.00 LMNA (0.52) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL20824955 0.87 ALDH1A1 (0.52) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL5235095 0.81 KMT2A (0.64) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL6289914 0.81 KMT2A (0.64) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL7911619 0.81 KMT2A (0.64) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL845363 0.79 CA2 (0.61) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL845362 0.79 CA2 (0.61) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL19958893 0.79 LMNA (0.57) LMNAL3MBTL1CA2KMT2AALDH1A1
SCHEMBL4256710 0.79 CA2 (0.61) LMNAL3MBTL1CA2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190322675-A1 Pesticidally Active Heterocyclic Derivatives with Sulfer Containing Substituents SYNGENTA PARTICIPATIONS AG (CH) 2019-10-24 US disclosed
US-20170174675-A9 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator VERTEX PHARMACEUTICALS INCORPORATED 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174675-A9 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator CFTR, SCNN1G, SCNN1B LMNA 4048/4885L3MBTL1 4354/4885CA2 1110/4885
US-20190322675-A1 Pesticidally Active Heterocyclic Derivatives with Sulfer Containing Substituents DDT, ACHE, SQOR LMNA 3830/4885L3MBTL1 2780/4885CA2 1131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.